NCT00463372View on ClinicalTrials.gov

Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

May 31, 2007

Conditions
SchizophreniaSchizo-affective Disorder
Interventions
DRUG

PF-02545920

Trial Locations (1)

Unknown

Pfizer Investigational Site, George

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY